Proapoptotic anti-inflammatory drugs

Area of Science:

• Oncology
• Pharmacology

Background:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) are typically known for pain and inflammation relief.
• Their association with cancer treatment, particularly prostate cancer, is unconventional due to their perceived low toxicity.
• Prostaglandins are implicated in prostate cancer biology, but NSAID mechanisms are more complex.

Purpose of the Study:

• To review the potential of NSAIDs and their derivatives as prostate cancer therapeutics.
• To explore the diverse mechanisms of action of NSAIDs in prostate cancer.
• To highlight NSAIDs as potential oral, non-toxic agents for prostate cancer prevention and treatment.

Main Methods:

• Review of existing laboratory and clinical studies on NSAIDs and prostate cancer.
• Analysis of the molecular mechanisms of NSAID action in prostate cancer.
• Examination of selective cyclooxygenase-2 inhibitors, lipoxygenase inhibitors, and novel NSAID derivatives.

Main Results:

• NSAIDs and derivatives demonstrate activity against established and potentially de novo prostate cancer.
• Mechanisms include direct and indirect inhibition of eicosanoid formation.
• Interference with cyclic guanosine monophosphate function is also observed.

Conclusions:

• NSAIDs offer a promising, low-toxicity approach to prostate cancer management.
• Their multifaceted mechanisms of action warrant further investigation for therapeutic development.
• Novel NSAID derivatives represent a significant advancement in oral prostate cancer agents.